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Background: Whilst there has been no clear consensus on the potential for earlier diagnosis of lung cancer, recent
research has suggested that the time between symptom onset and consultation can be long enough to plausibly
affect prognosis. In this article, we present findings from a qualitative study involving in-depth interviews with patients
who had been diagnosed with lung cancer (n = 11), and people who were at heightened risk of developing the
disease (n = 14).
Methods: A grounded theory methodology was drawn upon to conduct thematic and narrative based approaches
to analysis.
Results: The paper focuses on three main themes which emerged from the study: i) fatalism and resignation in pathways
to help-seeking and the process of diagnosis; ii) Awareness of smoking risk and response to cessation information and
advice. iii) The role of social and other networks on help-seeking. Key findings included: poor awareness among
participants of the symptoms of lung cancer; ambivalence about the dangers of smoking; the perception of lung
cancer as part of a homogenisation of multiple illnesses; close social networks as a key trigger in help-seeking.
Conclusions: We suggest that future smoking cessation and lung cancer awareness campaigns could usefully capitalise
on the influence of close social networks, and would benefit from taking a ‘softer’ approach.Background
The possible influence of delays in diagnosis on survival
and the risk factors for delay in patients with cancer
have been the subject of considerable interest and con-
troversy for many years [1]. Survival from cancer in the
United Kingdom is poorer than that of other European
countries, and it has been suggested that this can be
attributed to a more advanced disease stage at presenta-
tion [2]. Cancers in the UK are diagnosed later and at
more advanced stages than in other European countries
with resulting low national survival rates [3]. The situ-
ation is particularly serious in the case of lung cancer,
where for up to 80% of patients, their disease is found to
be inoperable because it has been diagnosed too late [4].
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unless otherwise stated.bleak, with delays in the diagnosis of cancer being at-
tributed to both patient and healthcare system factors [5].
Corner et al. [6] reported that delays of up to a year follow-
ing the onset of worrying symptoms were not uncommon
before patients decided to seek medical help. This is in
contrast to much of Europe where delays can be far
shorter, and survival rates correspondingly higher [7,8]. In
the USA too, it has been found that delays in seeking treat-
ment can be shorter than in the UK, with Jensen et al. [9]
for example, reporting that such delays can be less than six
months. It is further evident that long-term smokers,
particularly those with other conditions such as Chronic
Obstructive Pulmonary Disease (COPD), and those living
alone are at a higher risk of taking longer to consult with
symptoms of lung cancer [10]. The reasons for this are a
complex mix of individual and psychosocial factors [11,12],
but it has been established that one recurring feature in
the case of lung cancer is that patients, regardless of how
well progressed their disease was, failed to recognise thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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noticed changes in their health status long before they
sought medical help [13].
As yet there is no clear consensus on the potential for
earlier diagnosis of lung cancer [14,15], although research
has suggested that the time between symptom onset and
consultation can often be long enough to plausibly affect
prognosis [10]. Moody et al. 2004 [16], for example, high-
light that the most effective curative option for lung can-
cer is surgery, and although this modality has not changed
significantly for many years [17], it can be highly effective
for patients with early stage disease. It is far less so for
those whose disease is more advanced. So it follows that a
significant impact on survival rates could be achieved if a
higher proportion of patients were diagnosed early enough
to benefit from potentially curative surgery.
Current government initiatives in the UK and other
countries, aimed at raising awareness of the early symp-
toms of lung cancer illustrate the importance being placed
on this issue at a policy level. The 2005 guidance from
the National Institute for Health and Clinical Excellence
(NICE) on the diagnosis and treatment of lung cancer,
for example, were recently updated to advise healthcare
professionals of important advances in management and
patient information strategies [18]. And research into
public awareness of cancers in the UK has also lately
been stimulated by the strategic input of the National
Awareness and Early Diagnosis Initiative (NAEDI) [19].
This initiative, launched in 2008 aimed to involve public
and third sector organisations to support activities that
promote the early diagnosis of cancer and has been ins-
trumental in establishing a number of local and national
cancer awareness projects [20].
In this paper, we present an analysis of interview data
collected as part of the Lung Symptom Interpretation and
Diagnosis Study (LUSID).1 The study aimed to investigate
the social factors which influence symptom recognition
and help-seeking behaviour, and focused on two distinct
groups:1) patients with an existing diagnosis of lung can-
cer; 2) those at heightened risk of developing the disease.
These groups were chosen in order to understand how
perceptions and action in relation to help-seeking might
change and develop across the illness trajectory.Method
This was a qualitative study which utilised the principles
of grounded theory [21] and aimed to systematically inter-
leave data collection, analysis, constant comparison and
theorizing in an attempt to produce a plausible represen-
tation of the world view of participants that was rooted in
their accounts, rather than being hypothesis driven. We
also drew on existing material that emerged as relevant to
our understanding as the analytical process developed.Data were collected in 2012 and 2013, and we were able
to included 25 participants from two groups; people with
an existing diagnosis of lung cancer (n = 11); and people at
a heightened risk of developing lung cancer (n = 14), i.e.
long term smokers (that is, people who have smoked
for over a year), and people with Chronic Obstructive
Pulmonary Disease (COPD). The study was situated in two
clinical settings in the North West of England. One was a
dedicated specialist lung clinic in a large regional hospital,
and the other was a local GP practice. All of the diagnosed
participants were recruited from the lung clinic along with
3 ‘at heightened risk’. The remaining ‘at heightened risk’
patients came directly via their GP, or from responding to
recruitment posters at the GPs clinic. Both the clinic and
the GP practice were situated in an area of high economic
deprivation on the outskirts of a major (UK) Northern
industrial city, and a large proportion of patients in both
settings lived locally. The mean age of the diagnosed
group was 69 years, and 64 years for those ‘at heightened
risk’. In the lung clinic setting, 3 patients who were
approached by their consultant declined to take part; 4 ‘at
heightened risk’ patients from the GP surgery declined. In
all cases initial contact was made via a health care profes-
sional (either the person’s GP or their consultant) who
obtained provisional consent, and passed their contact de-
tails on to the research team. A researcher then arranged
to conduct a 30-60 minute semi-structured interview
where written consent to participate was obtained. Partici-
pants were able to have a relative or carer present during
their interview, and 4 participants took up this option. 6
participants who gave verbal consent to be contacted, sub-
sequently chose not to go ahead with an interview and
were not included in the study (4 from the ‘at risk’ group,
and 2 who had been diagnosed). Resources permitted a
fieldwork period of six months, after which time we closed
recruitment. The study adheres to the RATS guidelines
for reporting qualitative studies.
Interview guides for the in-depth interviews were gener-
ated from themes emerging from an initial literature review
[22], formal and informal contacts with key informants,
and input from PPI (Public and Patient Involvement) rep-
resentatives. This comprised of formal consultations with
an established PPI network at the University of Manchester
(the PRIMER group).2 PRIMER were able to provide input
from an early stage of the project. Two representatives
from this PPI group also joined the project steering com-
mittee and contributed to aspects of the analysis (see
Acknowledgements). Ethical approval for the study was
obtained from the regional NHS ethics committee (REC
reference 12/NW/0592).
Analysis
The main topics included in the interview schedule cov-
ered participants’: current understanding of the early signs
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ness of symptoms; how relevant health related knowledge
was obtained; the role of social networks; triggers to seeking
treatment. The schedule was used flexibly however, and
developed as new lines of inquiry emerged. Interviews
were recorded and transcribed verbatim; transcripts were
anonymised.
Analysis followed the principles of grounded theory
[21]. Transcripts were examined using a process of
focused coding, categorisation and thematic development.
Following an initial analysis, emergent themes were dis-
cussed within the project team and with PPI representa-
tives in an ongoing process which enabled potential early
findings to inform subsequent interviews. This refinement
and incorporation continued throughout the fieldwork
period. Meanings drawn from relevant field notes and
interpretations arising during the process of the research
were also incorporated where resonant with the data.
Results
Three main themes emerged which encompassed key ele-
ments of participant experience in the context of this clin-
ical arena, these were: i) Fatalism and resignation towards
pathways to help-seeking and the process of diagnosis. ii)
Awareness of smoking risk and response to cessation in-
formation and advice. iii) The role of social and other
networks on help-seeking.
i) Fatalism and resignation towards pathways to
help-seeking and the process of diagnosis
A strong thread with our diagnosed participants was a
kind of fatalistic attitude towards post-diagnosis processes.
Cancer fatalism - the belief that death is inevitable when
cancer is present - has often been identified as a barrier to
participation in cancer screening, detection, and treatment
[23]. However, in this pure sense, it was not particularly
evident in our data. Elements of fatalism, where they were
apparent, were more akin to resignation about having to
go through a potentially painful and ultimately tenuous
(in terms of possible outcomes) treatment process. Partici-
pants essentially saw their treatment as external – some-
thing basically unpleasant that needed to be done to them,
rather than something they had any real agency over.
Participants were happy to ‘leave it to the doctor’ and
there were few instances where diagnosis appeared to
lead to more than a limited interest in the mechanics of
their illness, beyond a basic understanding of the treat-
ment processes that were being recommended. A similar
situation existed in relation to potentially worrying symp-
toms, or ones that might indicate the early stages of lung
cancer. When asked about symptoms that might have
been regarded as serious enough to seek medical help, for
example, this participant - who was shortly to undergo
surgery on his lung -commented:Probably as I feel now, you know, I’ve got a lot of
tightness in my chest and the occasional pains and
that, I would have thought that was relatively serious,
but in fact that wasn’t even beginning to happen
when I first, you know, went through the process, it’s
only in the last couple of weeks I began to feel this,
and I’m not even sure that it’s because I’m aware of it.
But up to that point I couldn’t say I had any clue that
it was anything serious, I just thought it was
something that, some pill might get rid of this cough
for me. (Participant 01)
Attitudes were similar in the ‘at risk’ group. Particu-
larly in terms of the potential to be resigned or even fa-
talistic about their prospects should they develop cancer.
(In this and the other extracts presented R = ‘respond-
ent’; I = ‘interviewer’.)
R: But even what I’ve got [COPD]; I just think to
myself, you know, you’re told you’ve got it. And I
thought, well, I’ve got it, you know, they’ve given me
medication. I struggle along as I do, and I thought,
well, I’ve got it, you know, get on with it. You have to
put up with it.
I: So you don’t really want to know more about it?
R: Not really, I’m not very good. I mean, I’ve been
very lucky over the years because, I mean, it’s only
since the last few years, say about the last five or six
years, that with the bowel and this, I started getting
all this. And beforehand, I was so healthy, you know,
I never had nothing. And I think I’m just one of these.
If I’ve got it, I take the medication. There’s days I’m
not very good, so I’ll go to the doctor and tell them
what it is, they’ll tell me what to do,or change my
inhalers and things. I just take it as it comes.
(Participant 21)
There was often the admission that looking out for, or
acknowledging the appearance of worrying symptoms
was something that people chose not to think about in
any formalised way. When prompted, participants would
usually mention some of the more serious (and not neces-
sarily early) symptoms of lung cancer such as coughing up
blood or severe pain. This attitude was also coupled with
a reticence about addressing the possibility of cancer, even
if symptoms might indicate this. While, if it cropped up in
an interview, ‘coughing up blood’ was universally acknowl-
edged as something warranting immediate medical atten-
tion, its appearance might be attributed to any number of
other lung problems apart from cancer. And, particularly
among some of the older respondents - who were likely to
be suffering from other age related illnesses - there was a
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together; they would attribute no special significance to
cancer as a particularly serious (i.e. potentially terminal)
disease, and make little differentiation between different
types of cancer. This 82 year old female participant re-
ported that:
R: I see it as a whole thing, you know the cancer and
the lung thing, my legs, I put it all together and just
think oh well that’s the way it is.
I: So if you did start coughing up blood or something
like that you wouldn’t be thinking ‘cancer’ you’d be
thinking, oh it’s more of the same?
R: Yeah if I was coughing blood up I’d send for the
doctor.
I: But you wouldn’t be specifically worried that it
must be cancer?
R: No I don’t think like that. No. I think I might have
burst a blood vessel. (Participant 07)
Information seeking, and the sources of information
that people found useful in relation to health matters
generally, and lung cancer in particular, were surpris-
ingly limited. The majority of participants from both
groups indicated that they made frequent use of com-
puters and the internet. However, this tended to be fo-
cused on social activities such as staying in touch with
friends, rather than active information seeking. Among
the ‘at risk’ group there was little sense that health infor-
mation websites such as NHS direct were directly influen-
tial on knowledge and awareness about lung cancer – or
any other serious condition. Diagnosed participants who
used the internet generally reported that they had re-
searched their illness post-diagnosis, but their interest
remained relatively pragmatic; they might look up their
particular type of cancer to understand what the treat-
ment process would involve, but would not necessarily be
engaged in searches for alternative treatments or novel
cures. There was some evidence however, that close mem-
bers of respondents social and family networks might en-
gage in this type of activity:
My nephew has the internet, and he looked, I think
he was looking at it the other week. He went, good
God, [name], he said, this is not like just asthma or
anything. And I says, I know, sweet, I got told its one
over, you know, it’s crossed the line from asthma. . .
And he went, God, [name], it don’t look good on
there, how you could end up. And I thought, oh
brilliant. (Participant 21)ii) Awareness of smoking risk and response to cessation
information and advice
Interviewees were specifically asked for views on the
current and past (UK) health awareness campaigns – in-
cluding a recent national (UK) TV campaign that directly
focused on watching for the early symptoms of lung can-
cer, and more general campaigns aimed at emphasising
the dangers of smoking. It was clear that smokers parti-
cularly disliked the more graphic current TV adverts, and
ignored them almost as a matter of principle.
R: what I did was, right, rather than look, I just used
to turn over. But if I’d have not turned over and kept
watching it, which I should have done, then probably
I would have given up earlier.
I: So you think they would have had an impact on
you? If you’d have watched?
R: Yeah I do.
I: But you knew that they were going to give you a
message you didn’t want, so you’d turn it off?
R: That’s why I turned it off quick, yeah. Yeah.
And like when they came on the [cigarette] packets. . .
And I looked at what they - it could do - and I
thought, oh my God. I used to hide the packet, or put
them in a case. (Participant 19)
R: [Referring to graphic anti-smoking campaigns]
There’s always things on telly about smoking – giving
it up. In the newspapers there’s things about it as well.
The cigarette thing [referring to a recent advert] is
awful I must admit, but it doesn’t put me off
whatsoever. (Participant 16)
Participants tended to be ambivalent about the effects
of smoking and, if they were still smoking, the likelihood
that they would attempt to give up. On the one hand,
participants would readily admit that there was a real
risk of lung cancer (or other health implications) if they
continued to smoke. But on the other, the reasons they
cited for not giving up outweighed this. Several diagnosed
participants, for example, reported that they continued to
smoke but justified the situation by saying that the stress
of giving up would make their lives more difficult; they
regarded the damage as having already being done. Cut-
ting down was often seen as an acceptable compromise.
All participants who smoked reported having been advised
to stop by their doctor. However, as with overly graphic or
instructional anti-smoking media campaigns, the way in
which this issue was broached in a consultation had a sig-
nificant impact on whether or not the advice was taken.
‘Softer’ approaches from health care professionals tended
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tional communication styles:
He [the surgeon] was really nice and he was…you
know, he said, look, he said, you can smoke, if you
want to, but we would prefer it if you didn’t smoke, at
least two weeks before you’re due to have your
operation, I mean, I had to go and have all the tests to
see if I was fit enough to have the operation and
then…and I said, right, okay, and, I think, July, I gave
up in the July as I had my op in the September, or I
might have had the odd puff on a cigarette, maybe
two drags of a cigarette if I’m honest.” (Participant 22)
[Commenting on a doctor who forcefully told her to
stop smoking] It makes you feel worse, rather than better.
You know, I like it- if I go to a doctor – and he’ll say, well
there’s no good point me telling you to stop smoking,
you’ve been smoking all your life.
It’s up to you. That is better than a doctor coming
right out and saying stop smoking now.
No way. I mean I was told to stop when I had my
stroke. They said I’d be dead within 10 years if I didn’t
stop smoking. . . oh he [the doctor] was awful. He was
nasty. I couldn’t believe a doctor was like that. It was
because I was in [nurses] uniform and I smoked. And
I was furious with him and I said I will not stop
smoking, nobody tells me what to do. (Participant 16)
Most participants said they’d go to their doctor if they
started noticing persistent symptoms such as coughing,
or ‘a different kind of coughing’. However, as outlined
already, these wouldn’t necessarily be attributed to cancer,
or the possibility that these could be early symptoms.
There was little reference to the potential for lung cancer
to have a trajectory of symptoms or signs, and hardly any
acknowledgement that recent awareness raising cam-
paigns in the media specifically targeting this issue early
might have any influence.
iii) The role of social networks on help-seeking
It appeared that close family – particularly partners or
spouses – had the biggest impact on decisions about
when to seek medical help when symptoms of concern
became evident. This diagnosed participant was typical
in that after exhibiting symptoms for some time, it was
his partner who eventually persuaded him to go and see
his doctor:
I can’t believe, in fact I was bullied into going by
somebody else in the end, and in truth I probably
would have been longer before I went. (Participant 01)Members of extended networks, such as neighbours
reportedly had little influence unless they were regarded
as close friends, and participants noted that wider and
more nebulous networks such as those existing around ac-
tivity specific clubs or groups were even less important.
I: So can I ask you then, apart from doctors and
health professionals, who would you trust to give you
advice on your health and seeking advice, if you had
symptoms?
R: Well, I don’t…I mean, I think…I have a friend who
is a retired GP and I would trust her, but the trouble
is, everybody has got their different opinions as to
what’s the best thing to do.
I: And their own experience comes into it, doesn’t it,
whatever they’ve gone through?
R: Yes. So, no, I would, basically, go with what my GP
said really.
I: And your husband?
R: Well, yes, yeah.
I: But the trouble is, everybody has got their
different opinions as to what’s the best thing to do.
(Participant 03)
(In this extract, W is the respondent’s wife.)
R: Well it’s old wives tales isn’t it? People say oh you
don’t want to do that, you want to do this. You don’t
want to do this you want to do that. If I was going to
take anything seriously I’d take it off a doctor rather
than… [gestures towards his wife –both laugh]
W: Oh he doesn’t listen to me. No he doesn’t listen
to me.
R: Now and again you start and I say, oh I’ve got a bit
of a sore throat. You say, oh get one of these lozenges
down you. Things like that. But I mean anything big
time you know, I wouldn’t ask anybody in the pub or
[anything] like that. (Participant 15)
Friends, neighbours and acquaintances who had suf-
fered cancer, or cared for someone with the illness, how-
ever, were particularly valued as sources of informal
information and support. Again, it was not necessarily
important that these people had experienced the same
type of cancer as the participant, but rather that they
had had close involvement with serious life threatening
Chatwin et al. BMC Public Health 2014, 14:1043 Page 6 of 11
http://www.biomedcentral.com/1471-2458/14/1043illness. This gave them an experiential credibility that
others lacked:
I’ve just had a call from the MacMillan nurse who is
going to come around and, obviously, I’ve got a huge
regard for MacMillan nurses and, I suppose, just
talking to people who have had cancer and, you know,
I watched my brother-in-law not survive, but watched
other people survive and, you know, my own mother
battled on with it, it might have been better if she
hadn’t survive, because she was in a lot of pain, but
she had breast cancer in the late 50’s and survived
until she was 80, yes, in her 40’s and survived until
she was 80, so anecdotally, well, we all know people,
don’t we. (Participant 02)
Gender differences (or more specifically, the reinforce-
ment of gender stereotypes) were relatively undefined,
however all of the male participants in the study said
they tended to avoid going to the doctor for any reason,
and were usually pressurised into it by a spouse or family
member. The comment by this participant’s wife (W in
the transcript) emphasised how extreme these tendencies
could be:
I: [To male participant] So you’re the kind of person
who just battles through?
R: Yeah.
I: What would make you go to the doctor?
R: What would I go for to the doctor?
I: What would be serious enough for you to want to
go to the doctor, if there is anything?
W: If they were screwing the lid down on his coffin!
R: I’d have to be dying! I’d have to be dying, yeah.
I: So you wouldn’t normally.
R: No, no, no. (Participant 06)
Although reluctance to engage with medical services
in general was in evidence, it did not appear that ac-
tually going to the doctor was the issue. Rather, it
was the level or severity of symptoms that would trig-
ger a visit; these were very high in some people to
the point where they reported that they would have
to be in acute pain or state of debilitation before ini-
tiating contact themselves. Again, this links with the
finding that spouses and close family members werethe primary trigger for many people to seek medical
help.
R: In fact I’d go as far as to say if I hadn’t got a
girlfriend who had been pushing me it’d have
probably only been in the last fortnight I’d have gone
to the doctor because I’m beginning to, you know, feel
some symptoms now.
I: But even if you’d have gone now you still maybe
wouldn’t have connected it with cancer would you?
R: No, I wouldn’t…
I: …you’d have thought chest pains…
R: …not with chest pains no. (Participant 01)
Discussion
A striking feature of our data was the relatively limited
interest that participants appeared to have in the signs
and symptoms of lung cancer. This is perhaps understand-
able for those at heightened risk because even though it
was technically accurate to describe them as such, this cat-
egorisation does not appear to have been a major feature
of how they actually saw themselves on an everyday level.
There may have been a degree of avoidance occurring too,
so that people appeared reluctant to engage with the issue
not because they weren’t interested but because to do so
might be felt to be too pessimistic, or tempting fate in
some way. That this was also evident in our diagnosed
participants was perhaps surprising, but if thought of in
terms of avoidance or distancing being used as a con-
scious or un-conscious coping strategy [24], it becomes
more explicable. We did not undertake a specific measure
of psychological distress, and so are not able to provide
definitive evidence that this was in fact what our diag-
nosed participants were engaged in. However, a higher
level of distancing (which reportedly allows the patient a
greater capacity to gradually assimilate their situation,
rather than having to deal with it head on) has been asso-
ciated with lower levels of psychological stress in many
forms of cancer [25,26].
At a practical level, there have been some efforts to in-
vestigate the factors which influence how people judge
whether or not changes in their health status are serious –
and whether or not they decide to visit their doctor. Smith
et al. [10] for example, undertook a qualitative synthesis
of 32 research papers dealing with the help-seeking expe-
riences of patients with 20 different types of cancer (>775
patients and carers). They found that there were strong
similarities in patients across all cancer types, and that key
concepts were the recognition and interpretation of symp-
toms, and fear of the consultation. Focusing specifically
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who had recently been diagnosed with operable (early
stage), and inoperable (late stage) lung cancer. They con-
cluded that regardless of their disease stage, or their social
background, these individuals failed to recognise symp-
toms that they had experienced over many months prior
to their eventual diagnosis as particularly serious or
warranting medical attention. The findings of our study
resonate strongly with these two studies, but may further
indicate that a tangible and deliberate lack of engagement
with potentially serious symptoms (along with a clear
underlying knowledge that they may occur) is also at
work. The ‘downgrading’ of symptoms and the tendency
of people to attribute them to less serious illnesses when
they did occur was also evident in our data. This finding
is broadly in line with the literature on health related
help-seeking behaviour in general [27], but also registers
strongly with research more specifically focused on cancer
patients. A study by Mor et al. [28], for example, provided
a content analysis of remarks made by a corpus of 625
lung, breast and colorectal patients, and concluded that
patients suffering from lung or colorectal cancer were sig-
nificantly more likely to blame their symptoms on other
less serious illnesses, and thus delay seeking medical help.
Mor et al. [28] provide no specific data on the nature of
the health changes that patients failed to act upon, or
chose to downgrade. However later work, including that
of Tod et al. [4] and Braybrook, [29] is more definite, and
outlines symptoms such as persistent or irritating coughs,
changes in the weather, and ‘getting older’ as those that
patients routinely describe retrospectively after diagnosis.
Again, this is resonant with the accounts we collected.
Essentially, as Chapple et al. [30] suggest, there may be a
strong tendency for people to normalise symptoms.
An interesting detail to emerge was the tendency for
some participants (particularly those with lower socio-
economic status (SES) to bracket together any number
of different medical conditions. Breathlessness, joint prob-
lems, heart problems and different types of cancer were all
viewed as a kind of single homogenous condition. This
may reflect the predominance of low health expectations
in our sample, and an underlying acceptance of the inevit-
ability of physical decline, but it may also be connected to
a degree of ‘cancer fatalism’. This concept has been opo-
rationalized in different ways in the literature, and has
attracted a degree of philosophical as well as psychological
attention (See, for example, [31,32]). A number of studies
have established a link between people who have a lower
SES and higher levels of fatalism ([33-35]). Further, one
study of 2018 British adults found that people with low
SES were less positive about early cancer detection, and
more fearful about seeking help for a suspicious symptom
[34]. While a population based survey, also conducted in
the UK, reported a link between low SES, lower awarenessof cancer warning signs and greater anticipated delay in
seeking help [36]. In the context of this study we used
the term in a very broad sense to incorporate not only
the belief that an inevitable consequence of developing
cancer will be death [23], but that various lesser degrees
of resignation toward the trajectory of the illness can be
observed.
To date there has been a limited body of work focus-
sing directly on social networks and chronic illness,
although some research has dealt with aspects of social
support [37]. Distinctions have been drawn between the
strong social ties which develop through close personal
relationships such as those within families, versus weaker
ties with civil organizations and other more formal groups.
It has been suggested that groups with lower SES tend to
depend more on strong ties whilst the middle classes are
more adept at making use of weak ties [38,39]. This did
not appear to be the case, however. Although the import-
ance given to wider networks per se by participants was
broadly in line with studies which have identified the pro-
cesses of social network engagement, it was really only
very close family contacts that were reported to be influ-
ential in terms of cancer or other serious illness related
issues. This echoes recent research highlighting that the
greatest contribution to illness management within per-
sonal social networks of those with chronic illnesses,
comes from partners and close family members [38].
Age may have been a factor here as well: A recent multi-
cancer meta-analysis by Pinquart & Duberstein [40], for
example, examined 87 studies on the associations of
perceived social support, network size, and marital status,
and although levels of engagement varied by cancer type,
social network correlations were found to be generally
stronger in younger patients. Our sample was predomi-
nantly comprised of older individuals, and our findings
strongly support several other studies which have high-
lighted the role that very close family and spouses (as
opposed to slightly wider community networks) play in
prompting people to seek medical help when they notice
potentially serious symptoms. Along with straightforward
legitimisation of symptom severity – a theme which crops
up in work on a variety of cancers (see, for example,
[4,29]) – such close networks can also perform the func-
tion of actually sanctioning a visit to the doctor. This ‘legit-
imisation of the appointment’ was found to be particularly
important to male patients who were concerned that they
would not be seen as wasting the doctor’s time with trivial
symptoms, but the effect has been noted in some female
patients too [10]. The issue of informal network legitimisa-
tion is particularly relevant in the context of our study be-
cause it suggests that people who have limited engagement
with very close social networks may be at a disadvantage.
Early work by Goodwin et al. [41] noted significant
connections between marital status and diagnostic delay
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showing far more of a tendency to delay help-seeking
than those in stable or long term relationships. More re-
cently, Neal and Allgar [42] utilised the secondary ana-
lysis of patient-reported data from the ‘National Survey
of NHS patients: Cancer’ to explore the relationship
between socio-demographic factors and the components
of diagnostic delay. And in line with the earlier findings
of Goodwin et al, Neal & Allgar [42] reported that across
six cancers (lung, breast, colorectal, ovarian, prostate, and
non-Hodgkin’s lymphoma), it was single and separated/
divorced people who had delayed longer than married
people in seeking medical help.
Unusually, considering that recent data collated by
Cancer Research UK indicates that smoking is directly
responsible for 90% of lung cancers [43], a number of
participants in our diagnosed group were either not cur-
rently smokers, or had never smoked. This gave us the
opportunity to explore the issue of smoking related
stigma – something which has been widely reported as
presenting difficulties for patients who have never smoked
[44]. Chapple et al. [30], for example, reported that non-
smokers felt particularly stigmatised because of the associ-
ation with smoking that lung cancer can have. In more
recent work too, Sun et al. [45] describe how non-smokers
with cancer often carry the stigma that their cancer is
self-induced, and can feel ostracized by the public and
abandoned by the oncology community. In our data,
however, negative issues such as these were not strongly
evident, even among those who had non-smoking related
lung cancer. Work by De Nooijer et al. [46] has suggested
that shame and embarrassment about symptoms actively
hinders early presentation and diagnosis, but again, this
was not the case in the people we interviewed. A possible
reason for this may be linked to the social expectations,
demographic makeup and age range in our corpus; none
of our participants, for example, were under 57 years of
age, and Menec & Perry [47] have suggested that stigma
related to lung cancer is more likely to be associated with
younger age groups.
The relationship between smoking and lung cancer
risk is almost universally acknowledged. In a study based
on data supplied by Cancer Research UK, Redeker et al.
[48] reported a 90% awareness of this association. How-
ever, other recent work by Simon et al. [49] on the de-
velopment of a robust cancer awareness measure clearly
demonstrated that understanding of the symptoms and
risk factors for lung cancer is very poor in the UK, with
38% of their large study sample unable to name a single
symptom. There is a growing body of research focusing
particularly on the psychological aspects of smoking
cessation campaigns. Recent work by Borelli [50], for
example, focused on the use of motivational interviews by
healthcare practitioners at the individual and group level,but acknowledge that decreasing the prevalence of smok-
ing will take multi-target, multi-channel and multi-method
approaches. Armitage & Arden [51] were also concerned
with the effects of motivational and volitional processes.
In a study involving 350 smokers, they randomising par-
ticipants to one of three groups who received either i) a
smoking awareness questionnaire; ii) the questionnaire
plus instruction to plan to quit; or iii) a questionnaire,
plan to quit and help with forming an implementation
plan. In line with the multi-method argument, Armitage &
Arden proposed that harnessing both motivational and
volitional processes would enhance the effectiveness of
smoking cessation programmes, and they in fact found that
considerably more people in the third group stopped
smoking than in the first. Significantly too, individuals who
were already motivated to stop smoking at the point of
entering the study had most success in giving up. In a simi-
lar vein, recent qualitative work by Park et al. [52] con-
cluded that although smokers often perceived smoking as
a high-risk activity for lung cancer and smoking related
diseases, this heightened concern in its self rarely moti-
vated individuals to seek screening.
These findings are in line with reports from our partic-
ipants over what would most influence them to stop
smoking – the consensus from smokers in both groups
being that individuals need to be self-motivated to stop
smoking (for whatever reason), and that without this basic
level of intention, any health promotion interventions are
likely to be unsuccessful. The almost universal rejection of
anti-smoking campaigns which are becoming ever more
graphic and hard hitting, is an issue that also needs to be
addressed if ‘hardened’ smokers are not to become alien-
ated and unreachable.
The ambivalent attitude towards the dangers of smok-
ing that we found in both our diagnosed and ‘at height-
ened risk’ groups, and a tendency for people to take a
relatively perfunctory attitude towards the potential
symptoms of lung cancer (or, if they were diagnosed, the
details of their illness) may have been influenced by the
particular social context of our corpus. Molassiotis et al.
2010 [5] outlined how certain socio-demographic, psycho-
social and clinical characteristics can have an influence on
the point at which a person first becomes aware of signifi-
cant symptoms. In a study involving 75 patients diagnosed
with a range of different cancer types, they found that
older age, negative beliefs about cancer, fears about the
consequences of having cancer, and reluctance to engage
with the process of receiving bad news all came into play.
Many of our participants were drawn from a relatively
poor working class area, and in contrast to more affluent
areas, smoking still carries far less of a general stigma than
among some other groups [53]. These findings tend to
support other work which has focused on the influence
of social background and attitudes towards smoking and
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reported by [6,10,49], while recent work by Beeken et al.
[34] found that – partly because of a greater tendency
towards fatalism over cancer that we outlined earlier in
this article –people with lower socio-economic status saw
it as less worthwhile to detect it and seek help early.
Limitations
Two main limitations of this study should be acknowl-
edged. The first concerns the sample size. While for an
in-depth qualitative study of this nature, the data corpus
can be considered to be entirely adequate, future studies
would perhaps benefit from a broader range of demo-
graphic representation. The study population was largely
drawn from a fairly deprived inner-city area, so the in-
clusion of more participants with a higher SES would be
useful in unpacking some of the social and generational
aspects of the data. Similarly more participants from
younger age groups would broaden the study. Another
limitation relates to the particular makeup of the ‘diag-
nosed’ group. Due to the requirements of the recruitment
process – which involved potential participants being
approached by a consultant during an appointment were
they may have just received the news that they had lung
cancer – it is likely that our sample is made up largely of
people who have a particular type of outlook. The nature
of the questions we were concerned with made this par-
ticular bias unlikely to influenced our findings, however,
in future work, it would be useful to find a way of recruit-
ing people with lung cancer by utilising different types of
health networks. The problem will always be, however,
that the aggressive nature of lung cancer gives researchers
a relatively short window of opportunity between diagno-
sis and the onset of treatment.
Conclusions
Against the backdrop of what is a significant issue in
terms of health promotion, there is now a strong policy
emphasis in the UK not only on helping people to give
up smoking, but also on raising awareness of the early
signs and symptoms of lung cancer. In this article we
have outlined three main themes that emerged from the
Lung Symptom Interpretation and Diagnosis Study.1 These
were: i) Fatalism and resignation in pathways to help-
seeking and the process of diagnosis. ii) Awareness of smok-
ing risk and response to cessation information and advice.
iii) The role of social and other networks on help-seeking.
We have tried to show that while our analysis confirms
the findings of several other studies (notably those con-
cerning the key role of close social networks, and the
tendency of people to play down or attribute symptoms
to other, less serious conditions), there are areas where
our results indicate some divergence from extant work.
In particular, we have described the phenomena wherebysome respondents homogenised groups of unrelated ill-
nesses, and the way in which this reflects a particular type
of fatalistic perspective.
In terms of how our findings might inform future
developments in health promotion and information pro-
vision in this area, we would suggest that a fruitful avenue
to pursue is one that is able to utilise the strong influence
of the close social networks we have described. Many of
the high impact and high shock value campaigns that
continue to be commissioned appear to have limited
impact on certain key groups – particularly people who
are hardened smokers. Campaigns that attempt to trigger
help-seeking or smoking cessation behaviour by proxy in
people close to those at heightened risk, rather than tar-
geting the individual themselves may be more effective.
Similarly, taking a ‘softer’ approach which does not imme-
diately alienate users may be a better way to engage some
groups. As our study has indicated, the present cycle of
ever more graphic campaigns often cause those who may
essentially be utilising mechanisms of denial or distancing
(in the broadest sense) to ‘switch off ’. Similarly, we would
suggest that – particularly among lower SES communities
where smoking is still extremely prevalent – it may be
counter-productive to rely on the effect of smoking stig-
matisation which has become a feature of more affluent
sectors of society. There does appear to be potential to
engage with people on a more conciliatory level, although
it should be noted that early evaluations on the effect of
the most recent ‘non-threatening’ or ‘soft’ national media
campaigns linking smoking cessation and lung cancer
awareness are at best, inconclusive (see, for example,
Durkin et al. 2012) [54]. At root, it may be that, as Sweeny
et al. [55] point out, although acquiring information can
provide numerous benefits, people often opt to avoid en-
gaging with it.
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